Hydreight Technologies Inc. Announces Closing of Oversubscribed $15 Million Bought Deal LIFE Offering
Globenewswire· 2026-01-27 13:30
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS, OTC: HYDTF, FSE: SO6) ("Hydreight" or the "Company"), a leader in U.S. nationwide digital healthcare solutions, is pleased to announce that, further to the news release of the Company dated January 15, 2026, it has closed its previously announced "bought deal" private placement with Canaccord Genuity Corp. ( ...
High Roller Technologies Provides Shareholder Update Highlighting Strategic Expansion into U.S. Prediction Markets
Globenewswire· 2026-01-27 13:30
Planned 2026 Launch of Prediction Markets Product with Crypto.com | Derivatives North America (CDNA) U.S. Prediction Markets Estimated by Eilers and Krejcik Gaming (EKG) to Exceed $1T in Trading Volume and $10B in Revenue in 2030 1 Las Vegas, Nevada, Jan. 27, 2026 (GLOBE NEWSWIRE) -- High Roller Technologies, Inc. (NYSE American: ROLR) (“High Roller” or the “Company”), operator of the award-winning, premium online casino brands High Roller, and Fruta, today issued a shareholder update highlighting key devel ...
Amaze to Sponsor SoCom 2026
Globenewswire· 2026-01-27 13:30
The AI-powered e-commerce platform deepens commitment to creator-led retail by hosting two exclusive events at SoComNEWPORT, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Amaze Holdings, Inc. (NYSE American: AMZE) (“Amaze”) a global leader in creator-powered commerce, today announced its official sponsorship of the second annual SoCom Conference, the first dedicated social commerce conference. The event will take place in Venice Beach, Calif. on Feb. 26, 2026. SoCom, founded by Orca Co-Founder & CEO Max Benator ...
Virtuix Debuts Trading on Nasdaq Under Ticker Symbol “VTIX” Following 138% Year-over-Year Revenue Growth
Globenewswire· 2026-01-27 13:30
From Kickstarter Success and Shark Tank to Nasdaq Debut, Virtuix Pioneers Movement in AI-Generated Worlds and Is Ready to Scale Virtuix has released a new video showcasing how Gaussian splatting rapidly turns 360-degree camera footage into photorealistic 3D digital environments AUSTIN, Texas, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Virtuix Inc. (NASDAQ: VTIX), a leading developer of full-body virtual reality systems, today announced that its Class A ordinary shares will start trading today on the Global M ...
Safe Harbor Expands Payments Solutions Portfolio to Help Cannabis Operators Cut Cash, Boost Stability
Globenewswire· 2026-01-27 13:30
New partnerships with Lüt and GreenCard expand access to reliable, compliant payment options, strengthening flexibility, redundancy, and business continuity for operators.DENVER, Jan. 27, 2026 (GLOBE NEWSWIRE) -- SHF Holdings, Inc., d/b/a Safe Harbor (the “Company” or “Safe Harbor”) (NASDAQ: SHFS), a leading fintech platform serving the banking, lending, and financial services needs of the regulated cannabis and hemp industries, announced a strategic expansion of its payments solutions portfolio through par ...
Olenox Industries Inc. Begins Recommissioning of Pipeline
Globenewswire· 2026-01-27 13:30
CONROE, Texas, Jan. 27, 2026 (GLOBE NEWSWIRE) -- via IBN -- Olenox Industries Inc. (NASDAQ: OLOX) (“Olenox Industries” or the “Company”) is pleased to announce it has commenced the process of recommissioning its 162 miles of pipe as a wet gas pipeline. The recommissioned pipeline will be both a producer of NGLs (Natural Gas Liquids) and dry gas. NGLs are high-value products commonly used in blending lower grade crude through the midstream markets. The dry gas will be sold into the open market and open contr ...
Liquidia to Present Clinical Data Across Its Portfolio at the Pulmonary Vascular Research Institute 2026 Annual Congress
Globenewswire· 2026-01-27 13:30
MORRISVILLE, N.C., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company revolutionizing care for patients with challenging respiratory and vascular diseases, announced today the company will present three posters at the Pulmonary Vascular Research Institute (PVRI) 2026 Annual Congress to be held January 28 through February 1, 2026, in Dublin, Ireland. The presentations highlight clinical data in pulmonary arterial hypertension (PAH) and pulmonary hypertension as ...
Satellogic and HEO Establish Australia’s First Sovereign Sub-Meter Capability, Through Sale of NewSat-34™, a Legacy In-Orbit Satellite
Globenewswire· 2026-01-27 13:30
Sale of a legacy Mark IV-g satellite enables HEO to expand its specialised Non-Earth Imaging services while providing a dedicated on-orbit testbed that grants Australian interests priority access for remote sensing developmentSYDNEY, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Satellogic, Inc. (NASDAQ: SATL) and HEO today announced a landmark agreement that establishes a significant new pillar of Australian sovereign space capability. Through the full title acquisition of the in-orbit NewSat-34™ satellite, a legacy M ...
Fall in Love with Portillo's New Sauces and Red Hot Meal Deal This Valentine's Day
Globenewswire· 2026-01-27 13:30
CHICAGO, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Portillo's, the iconic Chicago-based fast-casual restaurant famous for its Italian beef sandwiches, char-broiled burgers, crinkle-cut fries, cake shakes and more, is heating up Valentine’s Day with the launch of five new flavor-packed dipping sauces available at all restaurants nationwide starting today. To celebrate the launch, Portillo’s is offering members of its loyalty program, Portillo’s Perks, an exclusive opportunity to dip, dunk and discover its bolder fl ...
Quoin Pharmaceuticals Announces Submission to Japanese MHLW for Orphan Drug Designation for QRX003 in Netherton Syndrome
Globenewswire· 2026-01-27 13:30
Core Viewpoint - Quoin Pharmaceuticals has received confirmation from the Japanese MHLW that its lead product candidate QRX003 qualifies for both Orphan Drug Designation and Fast Track regulatory review in Japan, aiming to self-commercialize the product if approved [1][3]. Group 1: Regulatory Designation - QRX003 has been granted Orphan Drug Designation by both the U.S. FDA and the European Medicines Agency in 2025, and is now seeking similar status in Japan [1][2]. - The MHLW's Orphan Drug Designation program offers benefits such as R&D subsidies, tax credits for clinical testing, reduced application fees, priority review, and ten years of market exclusivity if approved [2]. Group 2: Clinical Development - QRX003 lotion (4%) is currently being evaluated in two late-stage pivotal clinical trials for Netherton Syndrome, with enrollment expected to be completed in the first half of 2026 [3]. - Top-line data from these trials is anticipated in the second half of 2026, with a New Drug Application (NDA) submission planned for late 2026 or early 2027 [3]. Group 3: Company Strategy - The company plans to establish its own commercial infrastructure in Japan, which is one of the three core territories for QRX003 and other pipeline products [3]. - Quoin Pharmaceuticals is committed to completing the clinical development of QRX003 urgently to address the needs of patients suffering from Netherton Syndrome [3].